BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14986483)

  • 1. Splenic ellipsoids: an early target for deposition of AA amyloid induced in mink.
    Wien TN; Sørby R; Espenes A; Gunnes G; Nordstoga K; Landsverk T; Husby G
    Amyloid; 2003 Dec; 10(4):240-9. PubMed ID: 14986483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of glycosaminoglycan deposition in splenic AA amyloidosis induced in mink.
    Wien TN; Sørby R; Omtvedt LA; Landsverk T; Husby G
    Scand J Immunol; 2004 Dec; 60(6):600-8. PubMed ID: 15584971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid induction of experimental AA amyloidosis in mink by intravenous injection of amyloid enhancing factor.
    Sørby R; Espenes A; Landsverk T; Westermark G
    Amyloid; 2008 Mar; 15(1):20-8. PubMed ID: 18266118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of proteoglycans and glycosaminoglycans in splenic AA amyloid induced in mink.
    Wien TN; Omtvedt LA; Landsverk T; Husby G
    Scand J Immunol; 2000 Dec; 52(6):576-83. PubMed ID: 11119263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of apolipoprotein E with murine amyloid A protein amyloid.
    Kindy MS; King AR; Perry G; de Beer MC; de Beer FC
    Lab Invest; 1995 Oct; 73(4):469-75. PubMed ID: 7474917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation and absorption of serum amyloid A and apolipoprotein E fragments in the course of AA amyloidosis: a study in a mouse model.
    Sato J; Kotani K; Yamada T
    Ann Clin Lab Sci; 2014; 44(3):249-53. PubMed ID: 25117094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E and apolipoprotein A-1 knock-out mice readily develop amyloid A protein amyloidosis.
    Elliott-Bryant R; Cathcart ES
    Clin Immunol Immunopathol; 1997 Oct; 85(1):104-8. PubMed ID: 9325076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in amyloid A amyloid formation in apolipoprotein-E-deficient mice.
    Kindy MS; Rader DJ
    Am J Pathol; 1998 May; 152(5):1387-95. PubMed ID: 9588907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homozygous serum amyloid P component-deficiency does not enhance regression of AA amyloid deposits.
    Usui I; Kawano H; Ito S; Hamada Y; Ishihara T; Maeda S
    Amyloid; 2001 Jun; 8(2):101-4. PubMed ID: 11409030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deposition, Clearance, and Reinduction of Amyloid A Amyloid in Interleukin 1 Receptor Antagonist Knockout Mice.
    Watanabe K; Uchida K; Chambers JK; Ushio N; Nakayama H
    Vet Pathol; 2017 Jan; 54(1):99-110. PubMed ID: 27565681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum amyloid A protein in mink during endotoxin induced inflammation and amyloidogenesis.
    Foyn Bruun C; Rygg M; Nordstoga K; Sletten K; Marhaug G
    Scand J Immunol; 1994 Sep; 40(3):337-44. PubMed ID: 8091133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparan sulfate dissociates serum amyloid A (SAA) from acute-phase high-density lipoprotein, promoting SAA aggregation.
    Noborn F; Ancsin JB; Ubhayasekera W; Kisilevsky R; Li JP
    J Biol Chem; 2012 Jul; 287(30):25669-77. PubMed ID: 22654109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colocalization of apolipoprotein AI in various kinds of systemic amyloidosis.
    Sakata N; Hoshii Y; Nakamura T; Kiyama M; Arai H; Omoto M; Morimatsu M; Ishihara T
    J Histochem Cytochem; 2005 Feb; 53(2):237-42. PubMed ID: 15684336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of tissue and plasma glycosaminoglycans during experimental AA amyloidosis and acute inflammation. Qualitative and quantitative analysis.
    Snow AD; Kisilevsky R; Stephens C; Anastassiades T
    Lab Invest; 1987 Jun; 56(6):665-75. PubMed ID: 3599910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid A protein amyloidosis induced in apolipoprotein-E-deficient mice.
    Hoshii Y; Kawano H; Cui D; Takeda T; Gondo T; Takahashi M; Kogishi K; Higuchi K; Ishihara T
    Am J Pathol; 1997 Oct; 151(4):911-7. PubMed ID: 9327723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the serum amyloid A protein in acute phase plasma high density lipoprotein the precursor of AA amyloid fibrils?
    Baltz ML; Rowe IF; Caspi D; Turnell WG; Pepys MB
    Clin Exp Immunol; 1986 Dec; 66(3):701-8. PubMed ID: 3105937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of amyloid proteins AA and SAA as apolipoproteins of high density lipoprotein (HDL). Displacement of SAA from the HDL-SAA complex by apo AI and apo AII.
    Husebekk A; Skogen B; Husby G
    Scand J Immunol; 1987 Apr; 25(4):375-81. PubMed ID: 3107118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of proteoglycans associated with mouse splenic AA amyloidosis.
    Stenstad T; Magnus JH; Husby G
    Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):663-70. PubMed ID: 7980430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral proinflammatory cytokine and SAA generation profiles and spatio-temporal relationship between SAA and lysosomal cathepsin B and D in murine splenic monocytoid cells during AA amyloidosis.
    Phipps-Yonas H; Pinard G; Ali-Khan Z
    Scand J Immunol; 2004 Feb; 59(2):168-76. PubMed ID: 14871293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An immunohistochemical study of amyloid P component, apolipoprotein E and ubiquitin in human and murine amyloidoses.
    Cui D; Hoshii Y; Takahashi M; Kawano H; Iwata T; Ishihara T
    Pathol Int; 1998 May; 48(5):362-7. PubMed ID: 9704343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.